Showing 97–108 of 112 results

Vitrakvi 100 mg Alternative – Larocent (Larotrectinib) 100 mg Capsule | Incepta Pharmaceuticals

Larocent 100 mg (Larotrectinib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Vitrakvi (Bayer).

Pack: 12 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Vizimpro 45 mg Alternative – Dacocent (Dacomitinib) 45 mg Tablet | Incepta Pharmaceuticals

Dacocent 45 mg (Dacomitinib) by Incepta Pharmaceuticals. EGFR inhibitor for selected EGFR-mutated NSCLC. Reference brand: Vizimpro (Pfizer). Pack: 10 tablets. Prescription only; equivalence not established.

Votrient 200 mg Alternative – Pazorest (Pazopanib) 200 mg Tablet | Everest Pharmaceuticals

Pazorest 200 mg (Pazopanib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Votrient (Novartis). It belongs to the multitarget kinase inhibitor class and is used in selected advanced renal cell carcinoma and soft tissue sarcoma.

Active ingredient: Pazopanib
Strength: 200 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Votrient 200 mg Alternative – Zopanib (Pazopanib) 200 mg Tablet | Beacon Pharmaceuticals

Zopanib 200 mg (Pazopanib) Tablet by Beacon Pharmaceuticals. Reference brand: Votrient. multikinase inhibitor; used in selected advanced renal cell carcinoma and soft tissue sarcoma. Prescription medicine. Brand comparison does not establish interchangeability.

Votrient 400 mg Alternative – Zopanib (Pazopanib) 400 mg Tablet | Beacon Pharmaceuticals

Zopanib 400 mg (Pazopanib) Tablet by Beacon Pharmaceuticals. Reference brand: Votrient. multikinase inhibitor; used in selected advanced renal cell carcinoma and soft tissue sarcoma. Prescription medicine. Brand comparison does not establish interchangeability.

Xalkori 250 mg Alternative – Alkixen (Crizotinib) 250 mg Capsule | Everest Pharmaceuticals

Alkixen 250 mg (Crizotinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Xalkori (Pfizer). It belongs to the ALK/ROS1 kinase inhibitor class and is used in selected ALK-positive or ROS1-positive non-small cell lung cancer.

Active ingredient: Crizotinib
Strength: 250 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Xalkori 250 mg Alternative – Alkriz (Crizotinib) 250 mg Tablet | Beacon Pharmaceuticals

Alkriz 250 mg (Crizotinib) Tablet by Beacon Pharmaceuticals. Reference brand: Xalkori. ALK/ROS1 kinase inhibitor; used in molecularly selected non-small cell lung cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Xalkori 250 mg Alternative – Crizocent (Crizotinib) 250 mg Capsule | Incepta Pharmaceuticals

Crizocent 250 mg (Crizotinib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Xalkori (Pfizer).

Pack: 12 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Xeloda 500 mg Alternative – Capixet (Capecitabine) 500 mg Tablet | Everest Pharmaceuticals

Capixet 500 mg (Capecitabine) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Xeloda (Roche). It belongs to the oral fluoropyrimidine chemotherapy class and is used in selected colorectal, breast and other cancer regimens.

Active ingredient: Capecitabine
Strength: 500 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Xeloda 500 mg Alternative – Xitabin (Capecitabine) 500 mg Tablet | Beacon Pharmaceuticals

Xitabin 500 mg (Capecitabine) Tablet by Beacon Pharmaceuticals. Reference brand: Xeloda. oral fluoropyrimidine chemotherapy; used in selected colorectal and breast cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Xgeva 120 mg Alternative – Denosis (Denosumab) 120 mg Injection | Incepta Pharmaceuticals

Denosis 120 mg (Denosumab) Injection is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Xgeva (Amgen).

Pack: 1 vial. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Xtandi 40 mg Alternative – Zaluta (Enzalutamide) 40 mg Tablet | Beacon Pharmaceuticals

Zaluta 40 mg (Enzalutamide) Tablet by Beacon Pharmaceuticals. Reference brand: Xtandi. androgen receptor inhibitor; used in selected advanced prostate cancer. Prescription medicine. Brand comparison does not establish interchangeability.